Assessment of salivary gland function after 177Lu-PSMA radioligand therapy: Current concepts in imaging and management

Assessment of salivary gland function after 177Lu-PSMA radioligand therapy: Current concepts in imaging and management

Prostate specific membrane antigen (PSMA) is a transmembrane protein that is highly expressed on prostate epithelial cells and is strongly upregulated in prostate cancer. Radioligand therapy using beta-emitting Lutetium-177 (177Lu)-labeled-PSMA-617, a radiolabeled small molecule, has gained attentio...

Full description

Bibliographic Details
Main Authors: Sonia Mahajan, Ravinder K. Grewal, Kent P. Friedman, Heiko Schöder, Neeta Pandit-Taskar
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Translational Oncology
Subjects:
177Lu-PSMA-617
Radioligand therapy
Salivary gland dysfunction
Xerostomia
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523322001048

Internet

http://www.sciencedirect.com/science/article/pii/S1936523322001048

Similar Items